These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Opportunities with combined modality therapy for selective organ preservation in muscle-invasive bladder cancer. Colvett KT; Althausen AF; Bassil B; Heney NM; McGovern FV; Young HH; Kaufman DS; Zietman AL; Shipley WU J Surg Oncol; 1996 Nov; 63(3):201-8. PubMed ID: 8944067 [TBL] [Abstract][Full Text] [Related]
12. [III .Current Status of Bladder Preservation Therapy for Muscle Invasive Bladder Cancer]. Miyazaki J Gan To Kagaku Ryoho; 2018 Jan; 45(1):33-37. PubMed ID: 29362304 [No Abstract] [Full Text] [Related]
13. Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 64 patients. Montie JE J Urol; 2005 Jun; 173(6):1920-1. PubMed ID: 15879778 [No Abstract] [Full Text] [Related]
17. A bladder cancer multi-institutional experience with total cystectomy for muscle-invasive bladder cancer. Scher HI J Urol; 1994 Aug; 152(2 Pt 1):574-5. PubMed ID: 8015114 [No Abstract] [Full Text] [Related]
18. Bladder cancer: state-of-the-art care. Droller MJ CA Cancer J Clin; 1998; 48(5):269-84. PubMed ID: 9742894 [TBL] [Abstract][Full Text] [Related]
19. Superficial TCC bladder cancer: the impact of tumor differentiation on recurrence, progression and survival. Kurth KH Prog Clin Biol Res; 1984; 162A():307-18. PubMed ID: 6483914 [No Abstract] [Full Text] [Related]
20. [The treatment of invasive cancers of the bladder]. Whitmore WF J Urol (Paris); 1988; 94(7):337-43. PubMed ID: 3221103 [No Abstract] [Full Text] [Related] [Next] [New Search]